Endometriosis treatment with Dienogest Monotherapy or Dienogest associated to Intrauterine Dispositive of Levonorgestrel - a randomized clinical trial

niversidade Estadual de Campinas0 个研究点开始时间: 2024年7月16日最近更新: 2024年7月22日

适应症

试验速览

暂无简介。

•Women aged 18 to 45 years. Diagnosis of endometriosis by specific imaging examination ultrasound, magnetic resonance imaging (MRI). Present at study entry with complaints of pelvic pain and/or deep dyspareunia. Agree to the use of dienogest or levonorgestrel intrauterine device (LNG IUD). No contraindications to the use of levonorgestrel intrauterine device (LNG IUD). No desire for pregnancy during the one-year study period

•Asymptomatic women. Women who have not initiated sexual activity. Women with psychiatric or neurological disorders that compromise the ability to respond to the questionnaires developed such as schizophrenia, neurodegenerative disorders, severe depression. Women undergoing treatment for chronic systemic diseases that lead to painful symptoms fibromyalgia, interstitial cystitis, neuropathic pain. History of abdominal surgery hysterectomy, colectomy, exploratory laparotomy, complicated appendectomy

发起方

niversidade Estadual de Campinas